We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
(+4.5%)
Cap. Flow
-$8.74B
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$352M |
| 2 |
Merck
MRK
|
+$333M |
| 3 |
NVIDIA
NVDA
|
+$306M |
| 4 |
Atlassian
TEAM
|
+$280M |
| 5 |
Corteva
CTVA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$331M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$266M |
| 4 |
Danaher
DHR
|
+$240M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.76% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Watts Water Technologies
WTS
$13.1B
| $11.9M | ﹤0.01% |
81,625
-84
| -0.1% | -$12.1K |
|
1352
Cytek Biosciences
CTKB
$546M
| $11.9M | ﹤0.01% |
1,168,882
-171,042
| -13% | -$2.3M |
|
|
VRTV
1353
DELISTED
VERITIV CORPORATION
VRTV
| $11.9M | ﹤0.01% |
98,034
+37,874
| +63% | +$4.59M |
|
|
FOLD
1354
DELISTED
Amicus Therapeutics
FOLD
| $11.9M | ﹤0.01% |
975,292
-155,443
| -14% | -$1.75M |
|
|
EQC
1355
DELISTED
Equity Commonwealth
EQC
| $11.9M | ﹤0.01% |
476,324
+110,106
| +30% | +$2.81M |
|
1356
Stem
STEM
$52.7M
| $11.9M | ﹤0.01% |
66,359
-4,229
| -6% | -$1.02M |
|
|
AZPN
1357
DELISTED
Aspen Technology Inc
AZPN
| $11.8M | ﹤0.01% |
57,603
-39,024
| -40% | -$9.07M |
|
1358
Fox Class B
FOX
$23.9B
| $11.8M | ﹤0.01% |
415,649
-1,051
| -0.3% | -$30.1K |
|
|
SP
1359
DELISTED
SP Plus Corporation
SP
| $11.8M | ﹤0.01% |
340,360
-22,263
| -6% | -$768K |
|
1360
Marqeta
MQ
$1.66B
| $11.8M | ﹤0.01% |
483,012
-27,432
| -5% | -$749K |
|
|
CSW
1361
CSW Industrials
CSW
$5.71B
| $11.8M | ﹤0.01% |
101,781
-13,116
| -11% | -$1.57M |
|
1362
Synaptics
SYNA
$4.15B
| $11.8M | ﹤0.01% |
123,631
-21,104
| -15% | -$2.03M |
|
1363
Procept Biorobotics
PRCT
$1.17B
| $11.7M | ﹤0.01% |
281,376
+30,464
| +12% | +$1.31M |
|
1364
American States Water
AWR
$3.46B
| $11.7M | ﹤0.01% |
126,169
-4,263
| -3% | -$388K |
|
1365
La-Z-Boy
LZB
$1.69B
| $11.6M | ﹤0.01% |
508,835
-27,350
| -5% | -$665K |
|
1366
Bloomin' Brands
BLMN
$938M
| $11.6M | ﹤0.01% |
576,592
-290,889
| -34% | -$6.3M |
|
1367
NCR Voyix
VYX
$1.14B
| $11.6M | ﹤0.01% |
807,637
+256,658
| +47% | +$3.41M |
|
1368
Aaon
AAON
$7.77B
| $11.6M | ﹤0.01% |
230,465
-27,588
| -11% | -$1.29M |
|
1369
Moog Inc Class A
MOG.A
$12.8B
| $11.6M | ﹤0.01% |
131,758
+3,092
| +2% | +$259K |
|
|
NXGN
1370
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $11.5M | ﹤0.01% |
614,097
-19,060
| -3% | -$367K |
|
1371
RingCentral
RNG
$5.28B
| $11.5M | ﹤0.01% |
324,137
-24,150
| -7% | -$864K |
|
|
XRN
1372
Chiron Real Estate Inc
XRN
$477M
| $11.5M | ﹤0.01% |
241,609
-115,259
| -32% | -$5.21M |
|
1373
Nabors Industries
NBR
$1.21B
| $11.5M | ﹤0.01% |
73,947
-2,922
| -4% | -$436K |
|
|
SFBS
1374
ServisFirst Bancshares
SFBS
$4.86B
| $11.4M | ﹤0.01% |
166,099
+9,842
| +6% | +$735K |
|
1375
Cavco Industries
CVCO
$4.55B
| $11.4M | ﹤0.01% |
50,582
+2,276
| +5% | +$505K |
|
Similar funds
VFT
Nuveen's Q4 2022 Portfolio in Review
As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nuveen opened a new position in Atlassian worth $226M.
- Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
- Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
- Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
- Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
- Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
- Nuveen opened 40 new positions and closed 159 in Q4 2022.
- Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.
Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.